122 related articles for article (PubMed ID: 10591545)
1. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C.
Tai HL; Fessing MY; Bonten EJ; Yanishevsky Y; d'Azzo A; Krynetski EY; Evans WE
Pharmacogenetics; 1999 Oct; 9(5):641-50. PubMed ID: 10591545
[TBL] [Abstract][Full Text] [Related]
2. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity.
Tai HL; Krynetski EY; Schuetz EG; Yanishevski Y; Evans WE
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6444-9. PubMed ID: 9177237
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.
Salavaggione OE; Wang L; Wiepert M; Yee VC; Weinshilboum RM
Pharmacogenet Genomics; 2005 Nov; 15(11):801-15. PubMed ID: 16220112
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation.
Wang L; Sullivan W; Toft D; Weinshilboum R
Pharmacogenetics; 2003 Sep; 13(9):555-64. PubMed ID: 12972954
[TBL] [Abstract][Full Text] [Related]
5. Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus.
Kubota T; Chiba K
Br J Clin Pharmacol; 2001 May; 51(5):475-7. PubMed ID: 11422006
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.
Loennechen T; Yates CR; Fessing MY; Relling MV; Krynetski EY; Evans WE
Clin Pharmacol Ther; 1998 Jul; 64(1):46-51. PubMed ID: 9695718
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.
Feng Q; Vannaprasaht S; Peng Y; Angsuthum S; Avihingsanon Y; Yee VC; Tassaneeyakul W; Weinshilboum RM
Biochem Pharmacol; 2010 Apr; 79(7):1053-61. PubMed ID: 19945438
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
[TBL] [Abstract][Full Text] [Related]
9. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.
Wang L; Nguyen TV; McLaughlin RW; Sikkink LA; Ramirez-Alvarado M; Weinshilboum RM
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9394-9. PubMed ID: 15967990
[TBL] [Abstract][Full Text] [Related]
10. Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese.
Zhang JP; Zhou SF; Chen X; Huang M
Clin Chim Acta; 2006 Mar; 365(1-2):337-41. PubMed ID: 16223474
[TBL] [Abstract][Full Text] [Related]
11. Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics.
Rutherford K; Daggett V
J Mol Biol; 2008 Jun; 379(4):803-14. PubMed ID: 18482735
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.
Li F; Wang L; Burgess RJ; Weinshilboum RM
Pharmacogenet Genomics; 2008 Dec; 18(12):1083-94. PubMed ID: 18820593
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.
Yates CR; Krynetski EY; Loennechen T; Fessing MY; Tai HL; Pui CH; Relling MV; Evans WE
Ann Intern Med; 1997 Apr; 126(8):608-14. PubMed ID: 9103127
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.
Tai HL; Krynetski EY; Yates CR; Loennechen T; Fessing MY; Krynetskaia NF; Evans WE
Am J Hum Genet; 1996 Apr; 58(4):694-702. PubMed ID: 8644731
[TBL] [Abstract][Full Text] [Related]
15. [Frequency of thiopurine S-methyltransferase alleles in different ethnic groups living in Spain].
Corominas H; Domènech M; del Río E; Gich I; Domingo P; Baiget M
Med Clin (Barc); 2006 Mar; 126(11):410-2. PubMed ID: 16595084
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine S-methyltransferase (TPMT) genetic polymorphisms in Mexican newborns.
González-Del Angel A; Bermúdez-López C; Alcántara-Ortigoza MA; Vela-Amieva M; Castillo-Cruz RA; Martínez V; Torres-Espíndola L
J Clin Pharm Ther; 2009 Dec; 34(6):703-8. PubMed ID: 20175804
[TBL] [Abstract][Full Text] [Related]
17. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease.
Haglund S; Lindqvist M; Almer S; Peterson C; Taipalensuu J
Clin Chem; 2004 Feb; 50(2):288-95. PubMed ID: 14656901
[TBL] [Abstract][Full Text] [Related]
18. Scorpion primer PCR analysis for genotyping of allele variants of thiopurine s‑methyltransferase*3.
Yao P; Qu XM; Ren S; Ren XD; Su N; Zhao N; Wang L; Cheng L; Weng BB; Sun FJ; Huang Q
Mol Med Rep; 2020 Sep; 22(3):1994-2002. PubMed ID: 32705177
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine methyltransferase alleles in British and Ghanaian populations.
Ameyaw MM; Collie-Duguid ES; Powrie RH; Ofori-Adjei D; McLeod HL
Hum Mol Genet; 1999 Feb; 8(2):367-70. PubMed ID: 9931345
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance.
Krynetski EY; Evans WE
Pharmacology; 2000 Sep; 61(3):136-46. PubMed ID: 10971199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
